Literature DB >> 10469017

The prevalence of thyroid dysfunction in a population with borderline iodine deficiency.

N Knudsen1, T Jorgensen, S Rasmussen, E Christiansen, H Perrild.   

Abstract

OBJECTIVE: We lack information on the influence of borderline iodine deficiency on the occurrence of thyroid dysfunction. Iodine deficiency has been reported to facilitate the development of toxic nodular goitre, whereas a high iodine intake may increase the prevalence of autoimmune hypothyroidism. SUBJECTS AND METHODS: In a cross-sectional study of a random sample of the general population in our region with borderline iodine deficiency 2656 (65%) of 4073 men and women aged 41 to 71 years participated. Records were made of previous thyroidal illness. Blood samples were drawn for thyroid parameters and TPO Ab values. Iodine and creatinine was assessed in casual urine samples.
RESULTS: Previous or present hyperthyroidism was reported by 1.4% of the participants whereas 0.6% had unknown biochemical hyperthyroidism. All cases of undiagnosed hyperthyroidism were among women. Previously diagnosed and treated hypothyroidism was reported by 1.0% and undiagnosed hypothyroidism was found in 0.4%. Subclinical hyperthyroidism was found in 1.3% and subclinical hypothyroidism in 0.7%. TPO Ab titres >200 kU/l were found in 16.9% of the women and 6.6% of the men, and 83% of participants with TSH >5 mU/l had TPO Ab titres >200 kU/l. Participants with TPO Ab titres between 100 and 200 kU/l had no increased frequency of thyroid dysfunction. The median iodine excretion rate was estimated as 103 microg/day. Serum TSH values were higher in women than in men and showed higher dispersion in women as well as in old age. Serum free T3 was found to be higher in women than in men and increased with age. Serum free T4 showed no sex difference but values increased with increasing age.
CONCLUSION: In our region with borderline iodine deficiency more than 5% of the general population has clinical or subclinical thyroid dysfunction. We found a relatively high prevalence of hyperthyroidism, especially previously undiagnosed disease, but a low prevalence of hypothyroidism as would be expected in an area of iodine deficiency. Hypothyroidism was related to TPO Ab titres of >200 kU/l. Thyroid hormone levels varied with age and sex.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10469017     DOI: 10.1046/j.1365-2265.1999.00816.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  28 in total

1.  Mortality rate of chronically ill geriatric patients with subnormal serum thyrotropin concentration: a 2-yr follow-up study.

Authors:  Andrea Radácsi; Gábor Kovács; Wolfdieter Bernard; Joachim Feldkamp; Franz A Horster; István Szabolcs
Journal:  Endocrine       Date:  2003-07       Impact factor: 3.633

Review 2.  The incidence and prevalence of thyroid autoimmunity.

Authors:  Donald S A McLeod; David S Cooper
Journal:  Endocrine       Date:  2012-05-29       Impact factor: 3.633

3.  Undiagnosed thyroid dysfunction, thyroid antibodies, and iodine excretion in a Mediterranean population.

Authors:  Anna Lucas; María Teresa Julián; Ana Cantón; Conxa Castell; Roser Casamitjana; Eva María Martínez-Cáceres; María Luisa Granada
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

4.  Summary of scientific evidence.

Authors: 
Journal:  Occas Pap R Coll Gen Pract       Date:  2002-02

5.  The prevalence and determinants of hypothyroidism in hospitalized patients with type 2 diabetes mellitus.

Authors:  Fei Song; Cuiping Bao; Meiyu Deng; Hui Xu; Meijuan Fan; Stéphanie Paillard-Borg; Weili Xu; Xiuying Qi
Journal:  Endocrine       Date:  2016-09-07       Impact factor: 3.633

6.  Reference intervals for thyrotropin in an area of Northern Italy: the Pordenone thyroid study (TRIPP).

Authors:  R Tozzoli; F D'Aurizio; P Metus; A Steffan; C Mazzon; M Bagnasco
Journal:  J Endocrinol Invest       Date:  2018-01-16       Impact factor: 4.256

Review 7.  Global epidemiology of hyperthyroidism and hypothyroidism.

Authors:  Peter N Taylor; Diana Albrecht; Anna Scholz; Gala Gutierrez-Buey; John H Lazarus; Colin M Dayan; Onyebuchi E Okosieme
Journal:  Nat Rev Endocrinol       Date:  2018-03-23       Impact factor: 43.330

Review 8.  Autoantibodies in chronic hepatitis C: A clinical perspective.

Authors:  Janaína Luz Narciso-Schiavon; Leonardo de Lucca Schiavon
Journal:  World J Hepatol       Date:  2015-05-18

9.  Thyroid disorders in women of Puducherry.

Authors:  Rebecca Abraham; V Srinivasa Murugan; P Pukazhvanthen; S K Sen
Journal:  Indian J Clin Biochem       Date:  2009-05-08

Review 10.  Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints.

Authors:  Lee-Shing Chang; Romualdo Barroso-Sousa; Sara M Tolaney; F Stephen Hodi; Ursula B Kaiser; Le Min
Journal:  Endocr Rev       Date:  2019-02-01       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.